vs
Side-by-side financial comparison of Global Medical REIT Inc. (GMRE) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.
PUMA BIOTECHNOLOGY, INC. is the larger business by last-quarter revenue ($75.5M vs $38.4M, roughly 2.0× Global Medical REIT Inc.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 9.2%). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 4.6%).
Medical Properties Trust, Inc. (MPT) is an international real estate investment trust (REIT) based in Birmingham, Alabama that purchases and invests in healthcare facilities and for-profit healthcare holding companies, primarily in the United States and Europe. Their property acquisitions often come in the form of sale-leaseback agreements, in which the original property owner sells the property to MPT and becomes their tenant. MPT's tenants are generally subject to long-term triple net lease...
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
GMRE vs PBYI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $38.4M | $75.5M |
| Net Profit | $-6.1M | — |
| Gross Margin | — | 69.3% |
| Operating Margin | — | 22.7% |
| Net Margin | -16.0% | — |
| Revenue YoY | 9.2% | 27.7% |
| Net Profit YoY | -309.2% | — |
| EPS (diluted) | $-0.48 | $0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $38.4M | $75.5M | ||
| Q3 25 | $37.2M | $54.5M | ||
| Q2 25 | $38.0M | $52.4M | ||
| Q1 25 | $34.6M | $46.0M | ||
| Q4 24 | $35.2M | $59.1M | ||
| Q3 24 | $34.3M | $80.5M | ||
| Q2 24 | $34.2M | $47.1M | ||
| Q1 24 | $35.1M | $43.8M |
| Q4 25 | $-6.1M | — | ||
| Q3 25 | $-5.1M | $8.8M | ||
| Q2 25 | $585.0K | $5.9M | ||
| Q1 25 | $3.7M | $3.0M | ||
| Q4 24 | $2.9M | — | ||
| Q3 24 | $3.4M | $20.3M | ||
| Q2 24 | $-2.0M | $-4.5M | ||
| Q1 24 | $2.3M | $-4.8M |
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
| Q4 25 | — | 22.7% | ||
| Q3 25 | — | 17.6% | ||
| Q2 25 | — | 12.7% | ||
| Q1 25 | — | 8.7% | ||
| Q4 24 | — | 22.6% | ||
| Q3 24 | — | 27.4% | ||
| Q2 24 | — | -4.6% | ||
| Q1 24 | — | -5.3% |
| Q4 25 | -16.0% | — | ||
| Q3 25 | -13.6% | 16.2% | ||
| Q2 25 | 1.5% | 11.2% | ||
| Q1 25 | 10.8% | 6.5% | ||
| Q4 24 | 8.4% | — | ||
| Q3 24 | 9.9% | 25.2% | ||
| Q2 24 | -5.7% | -9.6% | ||
| Q1 24 | 6.6% | -11.0% |
| Q4 25 | $-0.48 | $0.26 | ||
| Q3 25 | $-0.45 | $0.17 | ||
| Q2 25 | $-0.01 | $0.12 | ||
| Q1 25 | $0.03 | $0.06 | ||
| Q4 24 | $-0.04 | $0.40 | ||
| Q3 24 | $0.14 | $0.41 | ||
| Q2 24 | $-0.05 | $-0.09 | ||
| Q1 24 | $0.01 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $9.1M | $97.5M |
| Total DebtLower is stronger | $1.2M | $22.7M |
| Stockholders' EquityBook value | $509.8M | $130.3M |
| Total Assets | $1.2B | $216.3M |
| Debt / EquityLower = less leverage | 0.00× | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $9.1M | $97.5M | ||
| Q3 25 | $7.1M | $94.4M | ||
| Q2 25 | $6.6M | $96.0M | ||
| Q1 25 | $5.4M | $93.2M | ||
| Q4 24 | $6.8M | $101.0M | ||
| Q3 24 | $5.7M | $96.7M | ||
| Q2 24 | $5.0M | $96.8M | ||
| Q1 24 | $1.3M | $107.2M |
| Q4 25 | $1.2M | $22.7M | ||
| Q3 25 | $1.2M | $34.0M | ||
| Q2 25 | $14.2M | $45.3M | ||
| Q1 25 | $14.3M | $56.7M | ||
| Q4 24 | $14.4M | $68.0M | ||
| Q3 24 | $14.5M | $79.3M | ||
| Q2 24 | $14.7M | $90.7M | ||
| Q1 24 | $25.7M | $102.0M |
| Q4 25 | $509.8M | $130.3M | ||
| Q3 25 | $485.3M | $115.3M | ||
| Q2 25 | $503.2M | $104.7M | ||
| Q1 25 | $517.4M | $97.1M | ||
| Q4 24 | $534.1M | $92.1M | ||
| Q3 24 | $542.6M | $71.1M | ||
| Q2 24 | $556.4M | $48.5M | ||
| Q1 24 | $575.0M | $51.0M |
| Q4 25 | $1.2B | $216.3M | ||
| Q3 25 | $1.3B | $202.9M | ||
| Q2 25 | $1.3B | $194.9M | ||
| Q1 25 | $1.3B | $196.2M | ||
| Q4 24 | $1.3B | $213.3M | ||
| Q3 24 | $1.2B | $220.7M | ||
| Q2 24 | $1.2B | $205.0M | ||
| Q1 24 | $1.3B | $214.1M |
| Q4 25 | 0.00× | 0.17× | ||
| Q3 25 | 0.00× | 0.30× | ||
| Q2 25 | 0.03× | 0.43× | ||
| Q1 25 | 0.03× | 0.58× | ||
| Q4 24 | 0.03× | 0.74× | ||
| Q3 24 | 0.03× | 1.12× | ||
| Q2 24 | 0.03× | 1.87× | ||
| Q1 24 | 0.04× | 2.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $73.6M | $14.4M |
| Free Cash FlowOCF − Capex | — | $14.4M |
| FCF MarginFCF / Revenue | — | 19.1% |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $41.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $73.6M | $14.4M | ||
| Q3 25 | $17.6M | $9.7M | ||
| Q2 25 | $22.1M | $14.1M | ||
| Q1 25 | $12.3M | $3.6M | ||
| Q4 24 | $70.0M | $15.6M | ||
| Q3 24 | $16.3M | $11.0M | ||
| Q2 24 | $18.9M | $1.0M | ||
| Q1 24 | $14.3M | $11.2M |
| Q4 25 | — | $14.4M | ||
| Q3 25 | — | $9.7M | ||
| Q2 25 | — | $14.1M | ||
| Q1 25 | — | $3.6M | ||
| Q4 24 | — | $15.6M | ||
| Q3 24 | — | $11.0M | ||
| Q2 24 | — | $1.0M | ||
| Q1 24 | — | — |
| Q4 25 | — | 19.1% | ||
| Q3 25 | — | 17.7% | ||
| Q2 25 | — | 26.8% | ||
| Q1 25 | — | 7.7% | ||
| Q4 24 | — | 26.4% | ||
| Q3 24 | — | 13.7% | ||
| Q2 24 | — | 2.1% | ||
| Q1 24 | — | — |
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | 0.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | 37.84× | 2.41× | ||
| Q1 25 | 3.28× | 1.21× | ||
| Q4 24 | 23.83× | — | ||
| Q3 24 | 4.81× | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | 6.18× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
